Summit Therapeutics Inc. · NASDAQ:SMMT
Summit Therapeutics Inc. shareholders
As of Sep 30, 2026, 291 institutions reported holding Summit Therapeutics Inc., 16.8% of its shares. Largest: Baker Bros. Advisors LP, Vanguard and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Summit Therapeutics Inc. | Change | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 32.8M | 4.1% | no change | Nov 16, 2026 |
| Vanguard | 15.2M | 1.9% | +3.37M | Nov 13, 2026 |
| BlackRock | 10.4M | 1.3% | +835K | Nov 13, 2026 |
| Fidelity | 8.14M | 1.0% | −1.91M | Nov 10, 2026 |
| State Street | 6.09M | 0.76% | −3.44M | Nov 12, 2026 |
| T. Rowe Price | 5.3M | 0.66% | +1.4M | Nov 16, 2026 |
| Citadel | 3.78M | 0.47% | +2.06M | Nov 16, 2026 |
| Geode Capital | 3.49M | 0.44% | +61,961 | Nov 6, 2026 |
| UBS | 3.22M | 0.40% | −2.1M | Nov 16, 2026 |
| Kynam Capital Management, LP | 3M | 0.38% | +1.8M | Nov 16, 2026 |